Results 301 to 310 of about 848,177 (365)

Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis. [PDF]

Medicina (Kaunas)
Lampsas S, Lambadiari V, Agapitou C, Lampsa A, Oikonomou E, Siasos G, Chatziralli I.   +6 more
europepmc   +1 more source

Effect of calcium dobesilate on macular microvasculature in patients with diabetic retinopathy. [PDF]

PLoS One
Kim JT, Lee KH, Lee MW.
europepmc   +1 more source

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the efficacy and safety of adding lobeglitazone to a triple therapy regimen in Korean patients with type 2 diabetes whose blood glucose levels were inadequately controlled despite dual therapy with metformin and sitagliptin.
Eun‐Gyoung Hong, Kyung‐Wan Min, SungWan Chun, Choon Hee Chung, Seungjoon Oh, Chang Beom Lee, Dong‐Jun Kim, Hye Soon Kim, Ji Oh Mok, Tae Seo Sohn, Jeong Hyun Park, Sung Hee Choi, Sungrae Kim, Sang Soo Kim, Kyu Yeon Hur, Chong Hwa Kim, Young Min Cho, Byung‐Joon Kim, Kun‐Ho Yoon   +18 more
wiley   +1 more source

N‐lactoyl amino acids are potential biomarkers for insulin resistance and diabetic complications

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims N‐lactoyl amino acids (Lac‐AA) are emerging as crucial players in metabolic research, with potential implications for disease mechanisms and therapeutic interventions. This study exploress the role of Lac‐AA in insulin resistance, type 2 diabetes (T2D), and its complications.
Khaled Naja, Asma A. Elashi, Najeha Anwardeen, Aleem Razzaq, Laila Hedaya, Shamma Almuraikhy, Ilhame Diboun, Karsten Suhre, Omar AlBagha, Mohamed A. Elrayess   +9 more
wiley   +1 more source

METTL3 blocked the progression of diabetic retinopathy through m6A-modified SOX2. [PDF]

Open Med (Wars)
Chen X, Ling Q, Xu J, Ye Y, Dong L.
europepmc   +1 more source

Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the risk of gastrointestinal adverse events in new users of glucagon‐like peptide‐1 receptor agonists (GLP‐1RA), sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) and insulin glargine. Materials and Methods We conducted an active comparator, new user design study in veterans with type 2 diabetes who initiated one of these drug
Amara Sarwal, Ravinder Singh, Guo Wei, Jincheng Shen, McKenna Nevers, Sydney E. Hartsell, Catherine G. Derington, Augustine Takyi, Akhil R. Chakravartula, Niharika Katkam, Robert E. Boucher, Stavros G. Drakos, Tom Greene, Srinivasan Beddhu   +13 more
wiley   +1 more source

Mitochondrial Fragmentation and Long Noncoding RNA <i>MALAT1</i> in Diabetic Retinopathy. [PDF]

Int J Mol Sci
Kowluru RA, Kumar J.
europepmc   +1 more source

Distribution of Ophthalmology Grant Opportunities and Variation Amongst Subspecialties in Australia

Clinical &Experimental Ophthalmology, EarlyView.
Benjamin Cook, Thomas Muecke, Stephen Bacchi, Weng Onn Chan   +3 more
wiley   +1 more source

Differential effects of lifestyle interventions on continuous glucose monitoring metrics in persons with type 2 diabetes: Potential for personalised treatment

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The effects of lifestyle on glucose metabolism significantly differ between individuals. Hyperglycaemia in type 2 diabetes is driven by tissue‐specific insulin resistance and reduced beta‐cell capacity, whose relative contribution varies between persons, potentially affecting the impact of lifestyle interventions. We quantified effects of
Iris M. de Hoogh, Tim Snel, Regina J. M. Kamstra, Tanja Krone, Albert A. de Graaf, Hanno Pijl   +5 more
wiley   +1 more source

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic foot complications are a growing challenge for both individuals and society, underscoring the need for medical treatments and reliable risk markers. This study aimed to identify circulating metabolites associated with the prevalence and incidence of diabetic foot complications in individuals with type 1 diabetes (T1D).
Jonas A. Andersen, Tommi Suvitaival, Kajetan Trošt, María J. Romero‐Lado, Simone Theilade, Ismo Matias Mattila, Marie Frimodt‐Møller, Anne Rasmussen, Peter Rossing, Cristina Legido‐Quigley, Tarunveer Singh Ahluwalia   +10 more
wiley   +1 more source